ZA954430B - Novel elastase inhibitors - Google Patents
Novel elastase inhibitorsInfo
- Publication number
- ZA954430B ZA954430B ZA954430A ZA954430A ZA954430B ZA 954430 B ZA954430 B ZA 954430B ZA 954430 A ZA954430 A ZA 954430A ZA 954430 A ZA954430 A ZA 954430A ZA 954430 B ZA954430 B ZA 954430B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- elastase inhibitors
- elastase
- compounds
- novel elastase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25279994A | 1994-06-02 | 1994-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA954430B true ZA954430B (en) | 1996-02-13 |
Family
ID=22957608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA954430A ZA954430B (en) | 1994-06-02 | 1995-05-30 | Novel elastase inhibitors |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0804465B1 (da) |
| JP (1) | JP3623799B2 (da) |
| KR (1) | KR100347285B1 (da) |
| CN (1) | CN1149877A (da) |
| AT (1) | ATE246708T1 (da) |
| AU (1) | AU689589B2 (da) |
| CA (1) | CA2189527C (da) |
| DE (1) | DE69531459T2 (da) |
| DK (1) | DK0804465T3 (da) |
| ES (1) | ES2199992T3 (da) |
| FI (1) | FI964781A (da) |
| HU (1) | HU221197B1 (da) |
| IL (1) | IL113940A (da) |
| NO (1) | NO965097L (da) |
| NZ (1) | NZ285565A (da) |
| PT (1) | PT804465E (da) |
| SI (1) | SI0804465T1 (da) |
| TW (1) | TW403762B (da) |
| WO (1) | WO1995033763A1 (da) |
| ZA (1) | ZA954430B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ287604A (en) * | 1994-06-02 | 1998-12-23 | Merrell Pharma Inc | Acylated enol derivatives as prodrugs of elastase inhibitors |
| EP0763055B1 (en) * | 1994-06-02 | 1999-11-03 | Merrell Pharmaceuticals Inc. | Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
| US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| ATE378334T1 (de) | 2003-05-21 | 2007-11-15 | Boehringer Ingelheim Int | Verbindungen als hepatitis c inhibitoren |
| ATE512971T1 (de) | 2004-07-20 | 2011-07-15 | Boehringer Ingelheim Int | Peptidanaloga als hepatitis c-hemmer |
| UY29016A1 (es) | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | Analogos de dipeptidos inhibidores de la hepatitis c |
| CA2651762A1 (en) | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| MX2009008518A (es) * | 2007-02-09 | 2009-08-20 | Irm Llc | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. |
| EP4031138A1 (en) | 2019-09-17 | 2022-07-27 | Mereo Biopharma 4 Limited | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
| AU2021256835A1 (en) | 2020-04-16 | 2022-10-13 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
| WO2023067103A1 (en) | 2021-10-20 | 2023-04-27 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
| DE3683541D1 (de) * | 1985-06-07 | 1992-03-05 | Ici America Inc | Selektionierte difluorverbindungen. |
| CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
| EP0564561A4 (en) * | 1990-12-28 | 1994-08-10 | Georgia Tech Res Inst | Peptides ketoamides, ketoacids, and ketoesters |
| AU655831B2 (en) * | 1991-08-22 | 1995-01-12 | Merrell Pharmaceuticals Inc. | Novel orally-active elastase inhibitors |
-
1995
- 1995-05-05 DE DE69531459T patent/DE69531459T2/de not_active Expired - Lifetime
- 1995-05-05 EP EP95918993A patent/EP0804465B1/en not_active Expired - Lifetime
- 1995-05-05 CN CN95193386A patent/CN1149877A/zh active Pending
- 1995-05-05 AT AT95918993T patent/ATE246708T1/de not_active IP Right Cessation
- 1995-05-05 ES ES95918993T patent/ES2199992T3/es not_active Expired - Lifetime
- 1995-05-05 WO PCT/US1995/005618 patent/WO1995033763A1/en active IP Right Grant
- 1995-05-05 HU HU9603312A patent/HU221197B1/hu not_active IP Right Cessation
- 1995-05-05 PT PT95918993T patent/PT804465E/pt unknown
- 1995-05-05 NZ NZ285565A patent/NZ285565A/en unknown
- 1995-05-05 CA CA002189527A patent/CA2189527C/en not_active Expired - Fee Related
- 1995-05-05 JP JP50087196A patent/JP3623799B2/ja not_active Expired - Fee Related
- 1995-05-05 SI SI9530682T patent/SI0804465T1/xx unknown
- 1995-05-05 AU AU24709/95A patent/AU689589B2/en not_active Ceased
- 1995-05-05 DK DK95918993T patent/DK0804465T3/da active
- 1995-05-05 KR KR1019960706818A patent/KR100347285B1/ko not_active IP Right Cessation
- 1995-05-30 ZA ZA954430A patent/ZA954430B/xx unknown
- 1995-05-31 IL IL11394095A patent/IL113940A/xx not_active IP Right Cessation
- 1995-05-31 TW TW084105515A patent/TW403762B/zh not_active IP Right Cessation
-
1996
- 1996-11-29 NO NO965097A patent/NO965097L/no not_active Application Discontinuation
- 1996-11-29 FI FI964781A patent/FI964781A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3623799B2 (ja) | 2005-02-23 |
| DE69531459D1 (de) | 2003-09-11 |
| CA2189527C (en) | 2000-12-19 |
| AU2470995A (en) | 1996-01-04 |
| MX9606030A (es) | 1998-05-31 |
| IL113940A0 (en) | 1995-08-31 |
| HU221197B1 (en) | 2002-08-28 |
| WO1995033763A1 (en) | 1995-12-14 |
| IL113940A (en) | 1999-12-31 |
| EP0804465A1 (en) | 1997-11-05 |
| NO965097L (no) | 1997-01-31 |
| ATE246708T1 (de) | 2003-08-15 |
| NO965097D0 (no) | 1996-11-29 |
| PT804465E (pt) | 2003-12-31 |
| HUT76926A (hu) | 1998-01-28 |
| JPH10500992A (ja) | 1998-01-27 |
| EP0804465B1 (en) | 2003-08-06 |
| CA2189527A1 (en) | 1995-12-14 |
| TW403762B (en) | 2000-09-01 |
| DE69531459T2 (de) | 2004-06-24 |
| DK0804465T3 (da) | 2003-11-24 |
| AU689589B2 (en) | 1998-04-02 |
| KR100347285B1 (ko) | 2003-01-15 |
| ES2199992T3 (es) | 2004-03-01 |
| FI964781A (fi) | 1997-01-29 |
| CN1149877A (zh) | 1997-05-14 |
| HU9603312D0 (en) | 1997-01-28 |
| FI964781A0 (fi) | 1996-11-29 |
| NZ285565A (en) | 1998-08-26 |
| SI0804465T1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105784A (en) | Triazole compounds with dopamine-d3-receptor affinity | |
| MX9706069A (es) | Nuevos inhibidores de la trombina. | |
| BG101112A (en) | The use of heterocyclic compounds | |
| PT695758E (pt) | Amidas e esteres de pentapeptidos inibidores de cancro humano | |
| GR3034208T3 (en) | Human neutrophil elastase inhibitors | |
| CA2189526A1 (en) | Perfluoroalkyl ketone inhibitors of elastase and processes for making the same | |
| GB9806632D0 (en) | Peptide factor | |
| YU60900A (sh) | Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja | |
| HU9603312D0 (en) | Novel elastase inhibitors | |
| AP2000001761A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
| GR3018304T3 (en) | Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones. | |
| BR9807883A (pt) | Compostos de tetraidropirido | |
| NZ330944A (en) | Peptide derivatives | |
| DE69726743D1 (de) | Peptid analoge, die einen siebengliedrigen lactamring enthalten | |
| MX9704796A (es) | Peptidos novedosos, su preparacion y uso. | |
| PE61999A1 (es) | Compuestos de tetrahidropiridina | |
| RU96102532A (ru) | Средство для лечения неврологических заболеваний |